Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brandon A Mahal

Showing results (71-80 of 214) with videos related to

Pageof 22
Sort By:
European Urology Open Science|September 4, 2023
Clinical and Genomic Factors Associated with Greater Tumor Mutational Burden in Prostate CancerHelen Y Hougen, Ryon P Graf, Gerald Li, et al.
Oncotarget|October 3, 2022
Genomic alterations predictive of poor clinical outcomes in pan-cancerCrystal S Seldon, Karthik Meiyappan, Hannah Hoffman, et al.
JCO Oncology Practice|February 25, 2021
Disparities in Refusal of Locoregional Treatment for Prostate AdenocarcinomaEdward Christopher Dee, Melaku A Arega, David D Yang, et al.
JCO Precision Oncology|August 29, 2024
A Targeted Methylation-Based Multicancer Early Detection Blood Test Preferentially Detects High-Grade Prostate Cancer While Minimizing Overdiagnosis of Indolent DiseaseBrandon A Mahal, Matthew Margolis, Earl Hubbell, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 7, 2019
Sociodemographic Disparities in the Receipt of Adjuvant Chemotherapy Among Patients With Resected Stage I-III Pancreatic AdenocarcinomaNina N Sanford, Todd A Aguilera, Michael R Folkert, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 31, 2019
Incidence and Demographic Burden of HPV-Associated Oropharyngeal Head and Neck Cancers in the United StatesBrandon A Mahal, Paul J Catalano, Robert I Haddad, et al.
European Urology|January 27, 2019
Prostate Cancer Genomic-risk Differences Between African-American and White Men Across Gleason ScoresBrandon A Mahal, Mohammed Alshalalfa, Daniel E Spratt, et al.
American Journal of Clinical Oncology|June 24, 2024
Modifiable Lifestyle Risk Factors in Adult Survivors of Childhood Cancer: A Nationally Representative StudyMinh D Ton, Jeffrey Shi Kai Chan, Danish Iltaf Satti, et al.
JCO Oncology Practice|June 1, 2023
Disparities in Diagnosis, Treatment Access, and Time to Treatment Among Hispanic Men With Metastatic Prostate CancerHelen Y Hougen, Nishwant Swami, Edward Christopher Dee, et al.
JCO Oncology Practice|October 28, 2021
Prostate Cancer Disparities in Risk Group at Presentation and Access to Treatment for Asian Americans, Native Hawaiians, and Pacific Islanders: A Study With Disaggregated Ethnic GroupsBhav Jain, Kenrick Ng, Patricia Mae G Santos, et al.
Pageof 22

Showing results (71-80 of 214) with videos related to

Sort By:
Pageof 22
European Urology Open Science|September 4, 2023
Clinical and Genomic Factors Associated with Greater Tumor Mutational Burden in Prostate CancerHelen Y Hougen, Ryon P Graf, Gerald Li, et al.
Oncotarget|October 3, 2022
Genomic alterations predictive of poor clinical outcomes in pan-cancerCrystal S Seldon, Karthik Meiyappan, Hannah Hoffman, et al.
JCO Oncology Practice|February 25, 2021
Disparities in Refusal of Locoregional Treatment for Prostate AdenocarcinomaEdward Christopher Dee, Melaku A Arega, David D Yang, et al.
JCO Precision Oncology|August 29, 2024
A Targeted Methylation-Based Multicancer Early Detection Blood Test Preferentially Detects High-Grade Prostate Cancer While Minimizing Overdiagnosis of Indolent DiseaseBrandon A Mahal, Matthew Margolis, Earl Hubbell, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 7, 2019
Sociodemographic Disparities in the Receipt of Adjuvant Chemotherapy Among Patients With Resected Stage I-III Pancreatic AdenocarcinomaNina N Sanford, Todd A Aguilera, Michael R Folkert, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 31, 2019
Incidence and Demographic Burden of HPV-Associated Oropharyngeal Head and Neck Cancers in the United StatesBrandon A Mahal, Paul J Catalano, Robert I Haddad, et al.
European Urology|January 27, 2019
Prostate Cancer Genomic-risk Differences Between African-American and White Men Across Gleason ScoresBrandon A Mahal, Mohammed Alshalalfa, Daniel E Spratt, et al.
American Journal of Clinical Oncology|June 24, 2024
Modifiable Lifestyle Risk Factors in Adult Survivors of Childhood Cancer: A Nationally Representative StudyMinh D Ton, Jeffrey Shi Kai Chan, Danish Iltaf Satti, et al.
JCO Oncology Practice|June 1, 2023
Disparities in Diagnosis, Treatment Access, and Time to Treatment Among Hispanic Men With Metastatic Prostate CancerHelen Y Hougen, Nishwant Swami, Edward Christopher Dee, et al.
JCO Oncology Practice|October 28, 2021
Prostate Cancer Disparities in Risk Group at Presentation and Access to Treatment for Asian Americans, Native Hawaiians, and Pacific Islanders: A Study With Disaggregated Ethnic GroupsBhav Jain, Kenrick Ng, Patricia Mae G Santos, et al.
Pageof 22